These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 15007390

  • 1. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
    Soejima H, Nakagawachi T, Zhao W, Higashimoto K, Urano T, Matsukura S, Kitajima Y, Takeuchi M, Nakayama M, Oshimura M, Miyazaki K, Joh K, Mukai T.
    Oncogene; 2004 May 27; 23(25):4380-8. PubMed ID: 15007390
    [Abstract] [Full Text] [Related]

  • 2. Lsh controls silencing of the imprinted Cdkn1c gene.
    Fan T, Hagan JP, Kozlov SV, Stewart CL, Muegge K.
    Development; 2005 Feb 27; 132(4):635-44. PubMed ID: 15647320
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
    Ribarska T, Ingenwerth M, Goering W, Engers R, Schulz WA.
    Cancer Genomics Proteomics; 2010 Feb 27; 7(2):51-60. PubMed ID: 20335518
    [Abstract] [Full Text] [Related]

  • 4. Methylation at mouse Cdkn1c is acquired during postimplantation development and functions to maintain imprinted expression.
    Bhogal B, Arnaudo A, Dymkowski A, Best A, Davis TL.
    Genomics; 2004 Dec 27; 84(6):961-70. PubMed ID: 15533713
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors.
    Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K.
    Oncogene; 2002 Apr 18; 21(17):2741-9. PubMed ID: 11965547
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y.
    J Pathol; 2007 Oct 18; 213(2):131-9. PubMed ID: 17724792
    [Abstract] [Full Text] [Related]

  • 7. Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome.
    Higashimoto K, Urano T, Sugiura K, Yatsuki H, Joh K, Zhao W, Iwakawa M, Ohashi H, Oshimura M, Niikawa N, Mukai T, Soejima H.
    Am J Hum Genet; 2003 Oct 18; 73(4):948-56. PubMed ID: 12949703
    [Abstract] [Full Text] [Related]

  • 8. Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA methylation analysis reveals that DMR-Lit1 is a putative imprinting control region.
    Yatsuki H, Joh K, Higashimoto K, Soejima H, Arai Y, Wang Y, Hatada I, Obata Y, Morisaki H, Zhang Z, Nakagawachi T, Satoh Y, Mukai T.
    Genome Res; 2002 Dec 18; 12(12):1860-70. PubMed ID: 12466290
    [Abstract] [Full Text] [Related]

  • 9. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC.
    Cancer; 2008 Apr 01; 112(7):1489-502. PubMed ID: 18286529
    [Abstract] [Full Text] [Related]

  • 10. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ.
    Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956
    [Abstract] [Full Text] [Related]

  • 11. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.
    Cancer Res; 2002 Jul 01; 62(13):3698-701. PubMed ID: 12097277
    [Abstract] [Full Text] [Related]

  • 12. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH.
    Cancer Res; 2003 Oct 01; 63(19):6178-86. PubMed ID: 14559801
    [Abstract] [Full Text] [Related]

  • 13. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.
    Carcinogenesis; 2004 May 01; 25(5):693-701. PubMed ID: 14729589
    [Abstract] [Full Text] [Related]

  • 14. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
    Lau JC, Hanel ML, Wevrick R.
    Nucleic Acids Res; 2004 May 01; 32(11):3376-82. PubMed ID: 15247330
    [Abstract] [Full Text] [Related]

  • 15. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 16. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
    Nakatsuka S, Liu A, Yao M, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, Aozasa K.
    Int J Oncol; 2003 Mar 15; 22(3):561-8. PubMed ID: 12579309
    [Abstract] [Full Text] [Related]

  • 17. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.
    Oncogene; 2007 Sep 27; 26(44):6456-68. PubMed ID: 17438526
    [Abstract] [Full Text] [Related]

  • 18. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
    Nakagawachi T, Soejima H, Urano T, Zhao W, Higashimoto K, Satoh Y, Matsukura S, Kudo S, Kitajima Y, Harada H, Furukawa K, Matsuzaki H, Emi M, Nakabeppu Y, Miyazaki K, Sekiguchi M, Mukai T.
    Oncogene; 2003 Dec 04; 22(55):8835-44. PubMed ID: 14647440
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C, Song JZ, Davidson B, Clark SJ.
    Cancer Res; 2004 Jun 01; 64(11):3871-7. PubMed ID: 15172996
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.